Zdrowie i gospodarka · 23/09/2022

FDA Issues Guidance on Exemption for Naloxone Distribution During Opioid Public Health Emergency

The Food and Drug Administration (FDA) has announced a final guidance for industry regarding the exemption of naloxone distribution to harm reduction programs during the ongoing opioid public health emergency, aiming to address the challenges faced by these programs in acquiring the medication.